Vimarsana
Biggest News Aggregation in the World

Page 2 - Thomask Equels News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomask Equels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomask Equels Today - Breaking & Trending Today

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - Vimarsana News

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Year marked by growing body of promising data demonstrating Ampligen’s potential to address multiple high-value indications Company to host conference call and webcast today, April 2nd at 8:30...

AIM ImmunoTech (AIM) Scheduled to Post Earnings on Tuesday - Vimarsana News

AIM ImmunoTech (AIM) Scheduled to Post Earnings on Tuesday

AIM ImmunoTech (NYSE:AIM – Get Free Report) will issue its quarterly earnings data on Tuesday, April 2nd. AIM ImmunoTech Trading Up 6.3 % Shares of NYSE AIM opened at $0.47 on Monday. AIM ImmunoTech has a one year low of $0.32 and a one year high of $0.75. The firm has a market capitalization of […]

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma - Vimarsana News

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma

Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET...

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 - Vimarsana News

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023

OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will...

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast - Vimarsana News

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

OCALA, Fla., March 26, 2024 -- AIM ImmunoTech Inc.   announced today that management will host a conference call and webcast to discuss the Company’s Q4/FY2023 operational and financial results...